EUVIMEDEUVIMED entdecken
Open Access

Oral vaccination with novel Lactococcus lactis mucosal live vector-secreting Brucella lumazine synthase (BLS) protein induces humoral and cellular immune protection against Brucella abortus

Zahra Fatehi, Abbas Doosti, Mohammad Saeid Jami

Archives of Microbiology · 2023

DOI: 10.1007/s00203-023-03471-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Microbiology, 2023. Verfasst von Zahra Fatehi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran. Hauptthemen laut MEDLINE: Lactococcus lactis, Brucella Vaccine. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This work aimed to provide recombinant Lactococcus lactis as a potential live vector for the manufacture of recombinant Brucella abortus (rBLS-Usp45). The sequences of the genes were collected from the GenBank database. Using Vaxijen and ccSOL, the proteins' immunogenicity and solubility were evaluated. Mice were given oral vaccinations with recombinant L. lactis. Anti-BLS-specific IgG antibodies were measured by ELISA assay. Cytokine reactions were examined using real-time PCR and the ELISA technique. The BLS protein was chosen for immunogenicity based on the vaccinology screening findings since it had maximum solubility and antigenic values ​​of 99% and 0.75, respectively. The BLS gene, digested at 477 bp, was electrophoretically isolated to demonstrate that the recombinant plasmid was successfully produced. Protein-level antigen expression showed that the target group produced the 18 kDa-sized BLS protein, whereas the control group did not express any proteins. In the sera of mice given the L. lactis-pNZ8148-BLS-Usp45 vaccine 14 days after priming, there was a significant level of BLS-specific IgG1, IgG2a (P < 0.001) compared to the PBS control group. Vaccinated mice showed higher levels of IFN-γ, TNFα, IL-4, and IL-10 in samples obtained on days 14 and 28, after receiving the L. lactis-pNZ8148-BLS-Usp45 and IRBA vaccines (P < 0.001). The inflammatory reaction caused less severe spleen injuries, alveolar edema, lymphocyte infiltration, and morphological damage in the target group's spleen sections. Based on our findings, an oral or subunit-based vaccine against brucellosis might be developed using L. lactis-pNZ8148-BLS-Usp45 as a novel, promising, and safe alternative to the live attenuated vaccines now available.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lactococcus lactisBrucella VaccineMiceAnimalsBrucella abortusVaccinationMice, Inbred BALB CMultienzyme Complexes

Stichwörter der Autor:innen

BLS proteinBrucellaLactococcus lactisMucosal live vector

Substanzen

Brucella Vaccine6,7-dimethyl-8-ribityllumazine synthaseMultienzyme Complexes

Autor:innen und Institutionen

  • Department of Biology, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran.
  • Biotechnology Research Center, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran. abbasdoosti@yahoo.com.
  • Cellular and Molecular Research Center, Basic Health Sciences Research Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.

Zitieren

APA

Fatehi, Z., Doosti, A., & Jami, M. S. (2023). Oral vaccination with novel Lactococcus lactis mucosal live vector-secreting Brucella lumazine synthase (BLS) protein induces humoral and cellular immune protection against Brucella abortus. Archives of Microbiology. https://doi.org/10.1007/s00203-023-03471-6

Vancouver

Fatehi Z, Doosti A, Jami MS. Oral vaccination with novel Lactococcus lactis mucosal live vector-secreting Brucella lumazine synthase (BLS) protein induces humoral and cellular immune protection against Brucella abortus. Archives of Microbiology. 2023. doi:10.1007/s00203-023-03471-6

BibTeX
@article{Fatehi2023,
  author = {Fatehi, Zahra and Doosti, Abbas and Jami, Mohammad Saeid},
  title = {Oral vaccination with novel Lactococcus lactis mucosal live vector-secreting Brucella lumazine synthase (BLS) protein induces humoral and cellular immune protection against Brucella abortus},
  journal = {Archives of Microbiology},
  year = {2023},
  doi = {10.1007/s00203-023-03471-6}
}
Kostenlos starten →